Healthcare professionals reached consensus that primary care practitioners did not have the capabilities to counsel men in relation to most aspects of prostate cancer care including PSA testing at diagnosis and treatment follow-up (Table 3, Statements 6–17), and moving services to primary care would create increased workload in secondary care through correspondence management (Table 3, Statement 1). This evidence concerns the gene KLK3 and prostate carcinoma.